International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...

Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in ...

In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...

US scientists have discovered an alarming syndrome linked to the most commonly used Covid jab in the UK as the number of ...